Concepedia

Madelynn N. Whittaker

MN

6

Publications

1.3K

Citations

6

H-Index

2020

Active since

Affiliations

Massachusetts General Hospital(Current)

Harvard University

University of Pennsylvania

Madelynn N. Whittaker is an author at Massachusetts General Hospital specializing in gene editing, molecular biology, and genetic engineering.

ORCID

Top concepts

Publications per year

2020–2024

6

Publications

6

Unconstrained genome targeting with near-PAMless engineered CRISPR-Cas9 variants

Russell T. Walton, Kathleen A. Christie, Madelynn N. Whittaker et al. · Science · 2020 · 1.2K citations · Full text

Treatment of monogenic and digenic dominant genetic hearing loss by CRISPR-Cas9 ribonucleoprotein delivery in vivo

Yong Tao, Verónica Lamas, Wan Du et al. · Nature Communications · 2023 · 44 citations · Full text

Efficient in vivo prime editing corrects the most frequent phenylketonuria variant, associated with high unmet medical need

Dominique L. Brooks, Madelynn N. Whittaker, Ping Qü et al. · The American Journal of Human Genetics · 2023 · 33 citations · Full text

Allele-specific silencing of the gain-of-function mutation in Huntington’s disease using CRISPR/Cas9

Jun Wan Shin, Eun Pyo Hong, Seri S. Park et al. · JCI Insight · 2022 · 29 citations · Full text

, , +12

High-fidelity PAMless base editing of hematopoietic stem cells to treat chronic granulomatous disease

Vera Bzhilyanskaya, Linyuan Ma, Siyuan Liu et al. · Science Translational Medicine · 2024 · 15 citations · Full text

Rows per page

1–5 of 6